Literature DB >> 19431954

Severe neonatal renal failure after maternal use of angiotensin II type I receptor antagonists.

M T Sinelli1, D Cattarelli, S Cortinovis, D Maroccolo, G Chirico.   

Abstract

Sartans are selective type 1 angiotensin II receptor antagonists that are used for treatment of arterial hypertension. We report a case of severe renal failure required dialysis after the use of olmesartan in the last month of pregnancy. Exposure to sartans during the last period of gestation seems to be associated with high risk of congenital malformations. It is important to stress that the use of these drugs during pregnancy must be avoided, especially in the third trimester.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19431954

Source DB:  PubMed          Journal:  Pediatr Med Chir        ISSN: 0391-5387


  2 in total

1.  Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature.

Authors:  Marc Oppermann; Stephanie Padberg; Angela Kayser; Corinna Weber-Schoendorfer; Christof Schaefer
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

Review 2.  Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review.

Authors:  Chisa Shimada; Rina Akaishi; Kazutoshi Cho; Mamoru Morikawa; Yosuke Kaneshi; Takahiro Yamda; Hisanori Minakami
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.